CompletedNot Applicable

Thoracic Extension and Global Postural Corrective Exercises on Individuals With Hyper Kyphosis

Pakistan30 participantsStarted 2025-01-13

Plain-language summary

The study was conducted to compare the effective of thoracic extension exercises and global postural corrective exercises on pain, range of motion and posture among hyperkyphotic individuals.

Who can participate

Age range

22 Years – 45 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age group between 18 and 48 years * Both gender male and female * Cobb angle ≥42°to\<60 degree * NPRS \> 3 * Mild to moderate scoring according to KSAQ Exclusion Criteria: * Congenital spinal deformity * Spinal, rib and clavicle fracture * Discogenic Disease * Autoimmune Disorder * History of spinal surgery * Structural Deformity * Systemic disease or inflammatory condition of spine

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Inclinometer

Timeframe: From enrollment to the end of treatment at 6 weeks

Numeric Pain Rating Scale (NPRS)

Timeframe: From enrollment to the end of treatment at 6 weeks

Kyphosis Specific Spinal Appearance Questionnaire (K-SAQ)

Timeframe: From enrollment till the end of treatment at 6 weeks

Cobb meter

Timeframe: From enrollment till the end of treatment at 6 weeks

Trial details

NCT IDNCT07426588

SponsorRiphah International University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-05-31

View on ClinicalTrials.gov More Hyperkyphosis trials

Who can participate

Age range

22 Years – 45 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Inclinometer

Timeframe: From enrollment to the end of treatment at 6 weeks

Numeric Pain Rating Scale (NPRS)

Timeframe: From enrollment to the end of treatment at 6 weeks

Kyphosis Specific Spinal Appearance Questionnaire (K-SAQ)

Timeframe: From enrollment till the end of treatment at 6 weeks

Cobb meter

Timeframe: From enrollment till the end of treatment at 6 weeks